
1001 - 5000 employees
Founded 2002
đ§Ź Biotechnology
đ Pharmaceuticals
đĽ Healthcare
đ° $661.3M Post-IPO Debt on 2025-09
Biotechnology ⢠Pharmaceuticals ⢠Healthcare
Alnylam Pharmaceuticals is a biopharmaceutical company that pioneers RNA interference (RNAi) therapeutics to silence disease-causing genes. The company develops RNAi-based medicines across rare and prevalent diseases, with a pipeline, approved products, and manufacturing capabilities focused on delivering transformational treatments (e. g. , for amyloidosis, acute hepatic porphyria, and primary hyperoxaluria). Alnylam emphasizes scientific innovation, patient-centered development, and corporate responsibility.
đĄ We watch Alnylam Pharmaceuticals's careers page
Every 2 hours
how often we check
7
roles posted in the last 30 days
Selected: đ Date Added.
đĽ 0 minutes ago
Business Account Executive promoting Alnylam Pharmaceuticalsâ AMVUTTRA RNAi therapy for TTR amyloidosis. Building provider relationships, driving product adoption, and achieving territory sales targets across South Alabama.
đ Alabama â Remote
đľ $144.5k - $195.5k / year
đ° $661.3M Post-IPO Debt on 2025-09
â° Full Time
đĄ Mid-level
đ Senior
đ§âđź Account Executive
đť Ghost score 0%
đĽ 0 minutes ago
Business Account Executive promoting Alnylamâs rare-disease RNAi therapies, GIVLAARIÂŽ and OXLUMOÂŽ. Driving physician engagement, patient identification, market development, and territory sales across Northern California and Southern Oregon.
đ California, Oregon â Remote
đľ $160.7k - $217.3k / year
đ° $661.3M Post-IPO Debt on 2025-09
â° Full Time
đĄ Mid-level
đ Senior
đ§âđź Account Executive
đť Ghost score 0%
đĽ 0 minutes ago
Business Account Executive commercializing Alnylamâs rare-disease therapies, GIVLAARIÂŽ and OXLUMOÂŽ. Driving physician and patient identification, market development, and territory sales across Upstate New York and Central Pennsylvania.
đ˝ New York, Pennsylvania â Remote
đľ $160.7k - $217.3k / year
đ° $661.3M Post-IPO Debt on 2025-09
â° Full Time
đĄ Mid-level
đ Senior
đ§âđź Account Executive
đť Ghost score 0%
đĽ 0 minutes ago
Associate Director advancing KOL engagement, TLL effectiveness, and field education at Alnylam Pharmaceuticals. Translating stakeholder insights into compliant commercial strategy and execution.
đşđ¸ United States â Remote
đľ $161.5k - $218.5k / year
đ° $661.3M Post-IPO Debt on 2025-09
â° Full Time
đ Senior
đ Director
đť Ghost score 0%
đĽ 0 minutes ago
Associate Director optimizing reimbursement access for Alnylamâs RNAi therapeutics across North Dakota, South Dakota, Minnesota, Iowa, and Wisconsin. Supporting providers, payers, and patient treatment pathways.
đž Iowa, North Dakota, +3 more states â Remote
đľ $174.3k - $235.7k / year
đ° $661.3M Post-IPO Debt on 2025-09
â° Full Time
đ Senior
đ Director
đť Ghost score 0%
đĽ 0 minutes ago
Area Sales Manager leading Key Account Manager teams across Northeast Germany for Alnylam Pharmaceuticals. Driving pharmaceutical sales strategy, market share, HCP education, and customer partnerships.
đŠđŞ Germany â Remote
đ° $661.3M Post-IPO Debt on 2025-09
â° Full Time
đ Senior
đ´ Lead
đ¤ Sales
đť Ghost score 12%
đŁď¸đŠđŞ German Required